Skip to main content

Table 6 Diagnosis, and treatment of Kawasaki disease shock syndrome, and Septic shock group

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS(n=13) SS (n=29) P value
Diagnosis
 Initial diagnosis of KD 23.1% (3/13) 0%(0/29) 0.025
 Complete KD 46.2% (6/13) 0%(0/29) 0.000
 Incomplete KD 38.5% (5/13) 3.4%(1/29) 0.007
Treatment
 1st IVIG 84.6% (11/13) 51.7% (15/29) 0.084
 2nd IVIG 76.9% (10/13) 17.2% (5/29) 0.000
 Oral prednisolone 7.7% (1/13) 0.0%(0/29) 0.310
 Methylprednisolone pulse therapy 38.5% (5/13) 0.0%(0/29) 0.002
 Infliximab 15.4% (2/13) 0.0%(0/29) 0.091
Antibiotics 92.3% (12/13) 100.0%(29/29) 0.310
  1. IVIG Intravenous immunoglobulin, KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome